Búsquedas



<< MENÚ PRINCIPAL - PROTOCOLOS DE ACTUACIÓN <<
INTRODUCCIÓN Y FISIOPATOLOGÍA
PROCEDIMIENTOS DIAGNÓSTICOS DE LA ETV
NUEVOS AGENTES ANTICOAGULANTES
PROFILAXIS DE LA ETV
PRONÓSTICO DEL TEP
TRATAMIENTO DEL ACCIDENTE TROMBOEMBÓLICO AGUDO
REFERENCIAS
CONSIDERACIONES PRÁCTICAS
PROFILAXIS SECUNDARIA EN PACIENTES CON CÁNCER




REFERENCIAS

1.- PREDILETTO R, PAOLETTI P, FORNAI E, et al. Natural course of treated pulmonary embolism. Chest 1990; 97: 554-61.

2.- OTERO-CANDELERA R, RODRÍGUEZ PANADERO F, RAMOS A, et al. Evolución de la gammagrafía pulmonar en el seguimiento del embolismo pulmonar. Arch Bronconeumol 1997; 33: 129-32.

3.- RIEDEL M. Long term follow-up of patients with pulmonary thromboembolism. Chest 1982; 81: 151-58.

4.- CARSON JL, KELLEY MA, DUFF A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-45.

5.- WELLS et al. Derivation of a simple clinical model to categorize patients´ probability of pulmonary embolism: increasing the model´s utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-20.

6.- WICKI et al. Asessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001; 161: 92-97.

7.-MINIATI et al. A structured clinical model for predicting the probability of pulmonary embolism. Am J Med 2003; 114: 173-79.

8.- BONAMEAUX H, PERRIER A. Role of D-Dimers in the exclusion of pulmonary embolism. Sem Respir Crit Care Med 1996; 17: 31-37.

9.-Perrier A, Desmarais S, Goehring C, de Moerloose P, Morabia A, Unger P, Slosman D, Junod A, Bounameaux H. D-Dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 1997; 156: 492-496.

10.-White RH, McGanan JP, Dashback MM, et al. Diagnosis of deep vein thrombosis using duplex ultrasound. Ann Intern Med 1989; 111: 297-304.

11.-Lensing A, Doris I, McGrath F, et al. A comparison of compression ultrasound with color doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. Arch Intern Med 1997; 157: 765-68.

12.- The PIOPED Investigators. Value of the Ventilation/Perfusion scan in acute pulmonary embolism. JAMA 1990; 263: 2753-59.

13-Hull RD, Raskob GE, Hirsch J. Low probability lung scans: a need for change. Ann Intern Med 1991; 114: 142-143.

14.- MINIATI M, PISTOLESI M, MARINI C, et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective investigative study of acute pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med1996; 154: 1387-93.

15.-Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the simple-breath-hold technique –comparison with pulmonary angiography. Radiology 1992; 185: 381-387.

16.-Remy-Jardin M, Remy J, Deschildre F, Artaud D, Beregi JP, Hossein-Foucher C, Merchandise X, Duhamel A. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996; 200: 699-706.

17.-Mayo JR, Remy-Jardin M, Müller NL, Remy J, Worsley DF, Hossein-Foucher C, Kwong JS, Brown MJ. Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology 1997; 205: 447-452.

18.-Kim KI, Müller NL, Mayo JR. The utility of spiral CT in clinically suspected pulmonary embolism. Radiology 1999; 210: 693-697.

19.-Goodman LR, Curtin JJ, Mewissen MW, Foley WD, Lipchik RJ, Crain MR, Sagar KB, Collier BD. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR 1995; 1369-1374.

20.-Teigen CL, Maus TP, Sheedy PF, Stanson AW, Johnson CM, Breen JF, and McKusik MA. Pulmonary embolism: diagnosis with contrast-enhanced electron-beam CT and comparison with pulmonary angiography. Radiology 1995; 194: 313-319.

21.-Van Rossum AB, Pattynama PM, Ton ER, Treurniet FE, Arndt JW, van Eck B, Kieft GJ. Pulmonary embolism: validation of spiral CT angiography in 149 patients. Radiology 1996; 201: 467-470.

22.-Drucker EA, Rivitz SM, Shepard JAO, Boiselle PM, Trotman-Dickenson B, Welch TJ, Maus TP, Miller SW, Kaufman JA, Waltman AC, McLoud TC, Athanasoulis CA. Acute pulmonary embolism: assessment of helical CT diagnosis. Radiology 1998; 209: 235-241.

23.-Garg K, Welsh CH, Feyerbend AJ, et al. Pulmonary embolism: diagnosis with spiral CT and ventilation-perfusion scanning -correlation with pulmonary angiographic results or clinical outcome. Radiology 1998; 208: 201-208.

24.-Rathbun SW, Raskow GE, Whitselt TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 2000; 132: 227-232.

25.-de Monye W, van Strijen MJ, Huisman MV, Kieft GJ, Pattynama PM. Suspected pulmonary embolism: prevalence and anatomic distribution in 487 consecutive patients. Radiology 2000; 215: 184-188.

26.-Ferretti GR, Bosson JL, Buffaz PD, Ayamian D, Pison C, Blanc F, et al. Acute pulmonary embolism: role of helical CT in 164 patients with intermediate probability at ventilation-perfusion scintigraphy and normal results at duplex US of the legs. Radiology 1999; 205: 453-458.

27.-Garg K, Sieler H, Welsh C, Johnston RJ, Russ PD. Clinical validity of helical CT being interpreted as negative for pulmonary embolism: Implications for patient treatment. AJR 1999; 172: 1627-1631.

28.-Lomis NN, Yoon HC, Moran AG, Miller FJ. Clinical outcomes of patients after a negative spiral CT pulmonary arteriogram in the evaluation of acute pulmonary embolism. J Vasc Interv Radiol 1999; 10: 707-712.

29.-Goodman LR, Lipchick RJ, Kuzo RS, Liu Y, McAuliffe TL, O´Brien DJ. Subsequent pulmonary embolism: risk after a negative helical angiogram –prospective comparison with scintigraphy. Radiology 2000; 215: 535-542.

30.-Swensen SJ, Sheedy PF, Ryu JH, Pickett DD, Schleck CD, Ilstrup DM, Heit JA. Outcomes after withholding anticoagulation from patients with suspected acute pulmonary embolism and negative computed tomographic findings: a cohort study. Mayo Clin Proc 2002; 77: 130-138.

31.-Gottsater A, Berg A, Centergard J, Frennby B, Nirhov N, Nyman M. Clinicalyy suspected pulmonary embolism: is it safe to withhold anticoagulation after a negative spiral CT? Eur Radiol 2001; 11: 65-72.

32.-Ost D, Rozenshtein A, Saffran L, Snider A. The negative predictive value of spiral computed tomography for the diagnosis of pulmonary embolism in patients with nondiagnostic ventilation-perfusion scans: Am J Med 2001; 110: 16-21.

33.-Tillie-Leblond I, Mastora I, Radenne F, Paillard S, Tonnel AB, Remy J, Remy-Jardin M. Risk of pulmonary embolism after a negative spiral CT angiogram in patients with pulmonary disease: 1-year clinical follow-up study. Radiology 2002; 223: 461-467.

34.-Musset D, Parent F, Meyer G, Maître S, Girard P, Leroyer Ch, Revel M-P, Carette M-F, Laurent M, Charbonier B, Laurent F, Mal H, Nonent M, Lancar R, Grenier P, Simonneau G. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicenter outcome study. Lancet 2002; 360:1914-20.

35.-van Strijen MJL, de Monyé W, Schiereck J, Kieft GJ, Prins MH, Huisman MV, Pattynama PMT. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 2003; 138: 307-14.

36:-Pérez de Llano LA, Veres A, López M, et al . Safety of withholding anticoagulant therapy in patients who have clinically suspected pulmonary embolism and negative results on helical CT. Eur Respir J 2003; Suppl 45. 218s.

37.-Heran F, Brenot F, Musset D, et al. Diagnostic value of selective digital substraction angiography in acute pulmonary embolism. Am Rev Respir Dis 1988; 137 (suppl): 186.

38.-Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism. Radiology 1999; 210: 689-691.

39.-Stein PD, Woodard PK, Hull RD, Kayali F, Weg JG, Olson RE, Fowler SE. Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review. Chest. 2003 Dec;124(6):2324-8.

40.-Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med 2003; 349: 1247-56.

41.- COLLINS R, SCRIMGOUR A, YuSUF S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-73.

42.- William H. Geerts, John A. Heit, MD, G. Patrick Clagett, Graham F. Pineo, Clifford W. Colwell, Frederick A. Anderson, and H. Brownell Wheeler. Prevention of venous thromboembolism. Chest 2201; 119: 132S-175S.

43.-Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 2003; 124: 379S-385S.

44.-Turpie AG, Bauer KA, Eriksson BL, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162: 1833-40.

45.-Francis CW, Berkowitz SD, Comp PC, et al. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 2003; 349: 1703-12.

46.-Colwell CW, Berkowitz SD, Davidson BL, et al. Randomized, double-blind, comparison of ximelagatran and enoxaparin to prevent VTE after total hip arthroplasty. Blood 2001; 98 (11): P 2952 (abstract).

47.-Kakkar VV, Howe CT, Flanc C, et al. Natural history of postoperative deep vein thrombosis. Lancet 1969; 6: 230-32.

48.-Carson JL, Kelly MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-45).

49.-Goldhaber SZ, Visani L, De Rosa M. ICOPER. Lancet 1999; 353: 1386-89.

50.-Moser KM, Auger WH, Fedullo PF. Chronic major-vessel thromboembolic hypertension. Circulation 1990; 81: 1735-43.

51.- Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti A, Santoro G, Conti A, Agnelli G, Berni G. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000 Jun 20;101(24):2817-22.

52.- Collomb D, Paramelle PJ, Calaque O, Bosson JL, Vanzetto G, Barnoud D, Pison C, Coulomb M, Ferretti G. Severity assessment of acute pulmonary embolism: evaluation using helical CT. Eur Radiol. 2003 Jul;13(7):1508-14.

53.- Mastora I, Remy-Jardin M, Masson P, Galland E, Delannoy V, Bauchart JJ, Remy J. Severity of acute pulmonary embolism: evaluation of a new spiral CT angiographic score in correlation with echocardiographic data. : Eur Radiol. 2003 Jan;13(1):29-35.

54.-Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84: 548-52.

55.-Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus HA. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation. 2000 Jul 11;102(2):211-7.

56.- Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003 May 27;107(20):2545-7.

57.-Prandoni P, Lensing AW, Cogo A, et al. The long term clinical course of acute venous thrombosis. Ann Intern Med 1996; 125: 1-7.

58.-Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thrmboembolism. N Engl J Med 1999; 340: 901-7.

59.-Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-96.

60.-Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 2000; 101: 2817-22.

61.-Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: Randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.

62.-Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. J Am Coll Cardiol 1992; 20: 520-26.

63.-Veillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27 (9): 1481-86.

64.-Verstraete M, Miller GAH, Bounameaux H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77: 353-60.

65.-Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-50.

66.-The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-62.

67.-Simonneau G, Sors H, Charbonier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-69.

68.-Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism. A Meta-Analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175-83.

69.-Hull R, Raskob G, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322: 1260-64.

70.-Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 2003; 139: 893-900.

71.-Schulman S, Rhedin A-S, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-65.

72.-Pinede L, Duhaut P, Cucherat M, et al. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials.

73.-The Research Committee of British Thoracic Society .Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873-76.

74.-Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348: 1425-34.

75.-Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity- warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-39.

76.-Schulman S, Granqvist S, Holmstrom M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 373-81.

77.-Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pegnant women with history of venous thromboembolism. N Engl J Med 2000; 343: 1439-44.

78.- Matisse Investigators. N Engl J Med 2003; 349: 1695-1702

79.-Schulman S, Wählander K, Lunström T, et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003: 349: 1713-21.

80.-Decousos H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-15.

81.-Moser KM, Daily PO, Peterson K, et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hipertension. Ann Intem Med 1987; 107: 560-65.

82.-Ghofrani HA, Schermuly RT, Rose F, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Ann Intern Med 2002; 136: 515-22.

83.-Bonderman D, Nowotny R, Skoro-sajer N, et al. Bosentan therapy for inoperable chronci thromboembolic pulmonary hipertensión. Chest 2005; 128: 2599-603.

84.-Hoeper MM, Kramm T, Wilkens H, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005; 128: 2363-67.

85.-Lopez JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology (Am Soc Hematol Educ Program). 2004; 439-56.

86.-Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001 Sep 4; 135(5):367-73.

87.-Perrier A, Roy PM, Sanchez O, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med. 2005 Apr 28; 352(17):1760-8.

88.-Ghanima W, Almaas V, Aballi S, et al. Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost. 2005 Sep; 3(9): 1926-32.

89.-van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006 Jan 11; 295(2):172-9.

90.-Nijkeuter M, Hovens MM, Davidson BL, et al. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest. 2006 Jan;129(1):192-7.

91.-Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005 Aug 8-22;165(15):1777-81.

92. Palareti, G, et al "D-Dimer Testing to Determine the Duration of Anticoagulation Therapy" N Engl J Med 2006; 355:1780-1789.